2m 2m 2m 2m 2m 2m 2m
ACRIVON THERAPE (ACRV)
NASDAQ
$1.63+$0.06 (+3.76%)
Price as of Nov 11, 2026 7:30 PM EST- $67.3MMarket Cap
- -24.15%1-Year Change
- BiotechnologyIndustry
ACRIVON THERAPE (ACRV)
$1.63+$0.06 (+3.76%)
ACRV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.57 | ||
Change | -$0.01 (-0.63%) | ||
Open | $1.57 | ||
High | $1.65 | ||
Low | $1.55 | ||
Previous Close | $1.58 | ||
Volume | 81,180 | ||
30-Day Average Volume | 190,828 | ||
1-Week Change | -5.99% | ||
1-Month Change | -17.80% | ||
1-Year Change | -24.15% | ||
3-Year Change | -64.11% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 42.9M | ||
Total Assets | $99.1M | ||
Market Cap | $67.3M | ||
Enterprise Value | $25.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.0M | ||
Free Cash Flow | -$14.9M | ||
EBIT | -$18.0M | ||
EBITDA | -$17.6M | ||
Net Working Capital | $80.0M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue